Literature DB >> 18440437

How best to deliver aerosol medications to mechanically ventilated patients.

Rajiv Dhand1, Vamsi P Guntur.   

Abstract

Pressurized metered-dose inhalers (pMDIs) and nebulizers are employed routinely for aerosol delivery to ventilator-supported patients, but the ventilator circuit and artificial airway previously were thought to be major barriers to effective delivery of aerosols to patients receiving mechanical ventilation. In the past two decades, several investigators have shown that careful attention to many factors, such as the position of the patient, the type of aerosol generator and its configuration in the ventilator circuit, aerosol particle size, artificial airway, conditions in the ventilator circuit, and ventilatory parameters, is necessary to optimize aerosol delivery during mechanical ventilation. The best techniques for aerosol delivery during noninvasive positive-pressure ventilation are not well established as yet, and the efficiency of aerosol delivery in this setting is lower than that during invasive mechanical ventilation. The most efficient methods of using the newer hydrofluoroalkane-pMDIs and vibrating mesh nebulizers in ventilator-supported patients also require further evaluation. When optimal techniques of administration are employed, the efficiency of aerosolized drug delivery in mechanically ventilated patients is comparable to that achieved in ambulatory patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440437     DOI: 10.1016/j.ccm.2008.02.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  16 in total

Review 1.  Aerosol delivery via noninvasive ventilation: role of models and bioanalysis.

Authors:  Haitham Saeed; Hadeer S Harb; Yasmin M Madney; Mohamed E A Abdelrahim
Journal:  Ann Transl Med       Date:  2021-04

2.  Usefulness of a handheld nebulizer in cough test to screen for silent aspiration.

Authors:  Yoko Wakasugi; Haruka Tohara; Ayako Nakane; Shino Murata; Shinya Mikushi; Chiaki Susa; Maho Takashima; Yoshiko Umeda; Ruriko Suzuki; Hiroshi Uematsu
Journal:  Odontology       Date:  2012-10-06       Impact factor: 2.634

Review 3.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 4.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

Review 5.  Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.

Authors:  Nashwa El-Gendy; Anubhav Kaviratna; Cory Berkland; Prajnaparamita Dhar
Journal:  Ther Deliv       Date:  2013-08

6.  Safety of Nebulized Epinephrine in Smoke Inhalation Injury.

Authors:  Guillermo Foncerrada; Francisco Lima; Robert P Clayton; Ronald P Mlcak; Perenlei Enkhbaatar; David N Herndon; Oscar E Suman
Journal:  J Burn Care Res       Date:  2017 Nov/Dec       Impact factor: 1.845

7.  Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation.

Authors:  Amar Safdar; Gilhen H Rodriguez
Journal:  Pharmacotherapy       Date:  2013-06-19       Impact factor: 4.705

Review 8.  Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients receiving mechanical ventilation in critical care units.

Authors:  Agi Holland; Fiona Smith; Kay Penny; Gill McCrossan; Linda Veitch; Caroline Nicholson
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

Review 9.  Colistin for lung infection: an update.

Authors:  Mohan Gurjar
Journal:  J Intensive Care       Date:  2015-01-22

10.  Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study.

Authors:  Jonathan Dugernier; Gregory Reychler; Xavier Wittebole; Jean Roeseler; Virginie Depoortere; Thierry Sottiaux; Jean-Bernard Michotte; Rita Vanbever; Thierry Dugernier; Pierre Goffette; Marie-Agnes Docquier; Christian Raftopoulos; Philippe Hantson; François Jamar; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2016-07-22       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.